Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2016

View Archived Issues

Novo Nordisk offers overview of fourth quarter 2015

Shionogi enters into research collaboration with PeptiDream

New funding supports Affinivax's development of novel pneumococcal vaccine

Olfactory receptors may be a therapeutic target for leukemia

FDA grants afamelanotide orphan drug designation for cutaneous porphyria

Peptide-based antigen-specific immunotherapy prevents anti-FVIII responses

GlaxoSmithKline's gepotidacin shows potential against anthrax

PapGene receives NCI grant to develop ovarian and endometrial cancer tests

Pozen and Tribute combine business and create Aralez Pharmaceuticals

New Ebola virus model developed in rhesus monkeys

Clinical trial data support the use of albutrepenonacog alfa in hemophilia B

BioAxone BioSciences receives fast track grant to support development of BA-1049

Piramal Enterprises discloses GPR120 agonists

Biota starts patient dosing in phase II trial evaluating topical BTA-074 antiviral gel

Bayer Schering Pharma patents GLUT-1 inhibitors

Celgene reports GLP-1 receptor ligands

Institute of Immunology and Experimental Therapy and IPO develop anticancer agents

ViiV Healthcare patent describes anti-HIV compounds

Lifesci Pharmaceuticals describes kallikrein inhibitors

Soricimed Biopharma's SOR-C13 receives U.S. orphan drug designation for ovarian cancer

FDA extends eteplirsen PDUFA date 3 months

Otsuka licenses U.S. rights for atopic dermatitis treatment OPA-15406 to Medimetriks

FDA accepts brexpiprazole sNDA for review

Ferring initiates phase IIIb PRONOUNCE trial of degarelix

FDA clears Sangamo's IND for SB-318

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...